Adenomas hipofisarios: hiperpituitarismos. Acromegalia. Prolactinomas. Enfermedad de Cushing. Otros hiperpituitarismos

Melmed, 2006, Acromegaly, N Engl J Med, 355, 2558, 10.1056/NEJMra062453 Lucas Morante, 2001, Acromegalia. Gigantismo, 53 Rajasoorya, 1994, Determinants of clinical outcome and survival in acromegaly, Clin Endocrinol (Oxf), 41, 95, 10.1111/j.1365-2265.1994.tb03789.x Mestron, 2004, Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espa?ol de Acromegalia, REA), Eur J Endocrinol, 151, 439, 10.1530/eje.0.1510439 Rosenow, 1996, Sleep apnea in treated acromegaly: relative frequency and predisposing factors, Clin Endocrinol (Oxf), 45, 563, 10.1046/j.1365-2265.1996.00852.x Jenkins, 2001, Clinical perspective: acromegaly and cancer: a problem, J Clin Endocrinol Metab, 86, 2935, 10.1210/jc.86.7.2935 Melmed, 2001, Acromegaly and cancer: not a problem?, J Clin Endocrinol Metab, 86, 2929, 10.1210/jc.86.7.2929 Renehan, 2002, Acromegaly and colorectal cancer: risk assessment should be based on population-based studies, J Clin Endocrinol Metab, 87, 1909, 10.1210/jc.87.4.1909 Trainer, 2000, Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant, N Engl J Med, 342, 1171, 10.1056/NEJM200004203421604 Gillam, 2006, Advances in the treatment of prolactinomas, Endocr Rev, 27I 5, 485, 10.1210/er.2005-9998 Molitch, 2001, Disorders of prolactin secretion, Endocrinol Metab Clin North Am, 30, 585, 10.1016/S0889-8529(05)70203-6 Molitch, 2002, Prolactinomas, 455 Moreno, 2005, Gu?a cl?nica del manejo del prolactinoma y otros estados de hiperprolactinemia, Endocrinol Nutr, 52, 9, 10.1016/S1575-0922(05)70971-2 Etxabe, 1994, Morbidity and mortality in Cushing's disease: an epidemiological approach, Clin Endocrinol, 40, 479, 10.1111/j.1365-2265.1994.tb02486.x Newell-Price, 2006, Cushing's syndrome, Lancet, 367, 1605, 10.1016/S0140-6736(06)68699-6 Arnaldi, 2003, Diagnosis and complications of Cushing's syndrome: A Consensus Statement, J Clin Endocrinol Metab, 88, 5593, 10.1210/jc.2003-030871 Findling, 2006, Cushing's Syndrome: important issues in diagnosis and management, J Clin Endocrinol Metab, 91, 3746, 10.1210/jc.2006-0997 Lamas, 2007, Metodolog?a diagn?stica en la identificaci?n del Cushing ect?pico, Endocrinol Nutr, 54, 432, 10.1016/S1575-0922(07)71477-8 Isidori, 2006, The ectopic ACTH syndrome: Clinical features, diagnosis, management and long-term follow-up, J Clin Endocrinol Metab, 91, 371, 10.1210/jc.2005-1542 Rees, 2002, Longterm follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission, Clin Endocrinol (Oxf), 56, 541, 10.1046/j.1365-2265.2002.01511.x Atkinson, 2005, Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance, Clin Endocrinol (Oxf), 63, 549, 10.1111/j.1365-2265.2005.02380.x Estrada, 1997, The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease, N Engl J Med, 336, 172, 10.1056/NEJM199701163360303 Colao, 1999, Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure, J Clin Endocrinol Metab, 84, 2664, 10.1210/jc.84.8.2664 Beckers, 2002, Etiolog?a de los d?ficits hormonales hipofisarios, 8